Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.
Phase 3 PATINA trial – summary Population - 518 patients with hormone receptor–positive, HER2-positive metastatic...
Phase 3 PATINA trial – summary Population - 518 patients with hormone receptor–positive, HER2-positive metastatic...
This study assessed how body mass index (BMI) at diagnosis affects outcomes in 834 patients with newly diagnosed multipl...
This study is a systematic review and meta-analysis evaluating frontline regimens for transplant-ineligible newly diagno...
This review article examines global patterns in acute myeloid leukemia (AML), emphasizing disparities between high-incom...
This publication reviews the emerging role of menin inhibition as a targeted strategy for acute leukemias characterized...
The publication reports on a novel therapeutic approach targeting cancer by exploiting specific molecular vulnerabilitie...